Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,34 USD | +0,86 % | -1,27 % | +1,30 % |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12/04/02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/04/02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14/04/13 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/10/07 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 09/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/04/02 |
Miriam Kidron
FOU | Founder | 83 | 12/04/02 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/10/07 |
Arie Mayer
BRD | Director/Board Member | 67 | 05/12/19 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 01/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 40 519 160 | 35 939 036 ( 88,70 %) | 0 | 88,70 % |
Información de la empresa
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,30 % | 94 M | |
+0,67 % | 42,19 mil M | |
+44,30 % | 40,15 mil M | |
-6,20 % | 28,31 mil M | |
+6,55 % | 24,63 mil M | |
-21,66 % | 18,2 mil M | |
+29,96 % | 12,01 mil M | |
-1,57 % | 11,76 mil M | |
+16,03 % | 10,4 mil M | |
-4,80 % | 9936,09 M |
- Bolsa de valores
- Acciones
- Acción ORMP
- Empresa Oramed Pharmaceuticals Inc.